Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jan
16
2016
Supreme Court Accepts 1st IPR Appeal: Cuozzo Could Mark Turning Point for Patent Owners Foley & Lardner LLP
Mar
14
2019
IP Considerations for Autonomous Vehicle Technology Startups and Automotive Suppliers Foley & Lardner LLP
Apr
3
2019
Right Tool, Right Job: Smart Manufacturing Requires Focus on Intellectual Property Foley & Lardner LLP
Feb
4
2016
Asset Transferee Cannot Appeal Reexamination Foley & Lardner LLP
Feb
9
2016
Federal Circuit Finds No "Way" To Support Doctrine Of Equivalents Foley & Lardner LLP
Nov
15
2023
USPTO Director Uses New Review Process to Order Independent Rehearing of PTAB Institution Decision Foley & Lardner LLP
Jun
25
2019
Federal Circuit Agrees “Pharmaceutical Composition” May Be Toxic Foley & Lardner LLP
Dec
11
2023
Startup Advisors: What Sources of Financing are Available to Startups? [VIDEO] Foley & Lardner LLP
Jul
9
2019
Automotive Market Intelligence Foley & Lardner LLP
Dec
20
2023
Startup Advisors: How to Prepare for a Financing [VIDEO] Foley & Lardner LLP
Mar
31
2016
USPTO Patent Quality Checklist Foley & Lardner LLP
Apr
6
2016
What "Reasonably" Could Have Been Raised in Inter Partes Review? Foley & Lardner LLP
Apr
11
2016
Methods Exploiting Junk DNA May Be Useful But Lack Patent Eligibility Foley & Lardner LLP
Oct
1
2019
PTAB Precedential 35 U.S.C. 315(b) Decisions Show Service in Dismissed Infringement Cases Can Still Bar IPR Institution Foley & Lardner LLP
Nov
13
2019
USPTO Updates Guidance on Patent-Eligibility of Personalized Therapy Foley & Lardner LLP
Dec
12
2019
American Rule Prevails; PTO May Not Collect In-House Attorneys' Fees as "Expenses" Foley & Lardner LLP
Mar
24
2020
Federal Circuit Finds Eligibility In Non-Diagnostic Method Foley & Lardner LLP
Jul
18
2016
Can You Identify Your Trade Dress? Foley & Lardner LLP
Jul
6
2020
USPTO Offers New Fast Track Appeals Pilot Program Foley & Lardner LLP
Oct
31
2016
USPTO Again Proposes To Revise Duty Of Disclosure In View Of Therasense Foley & Lardner LLP
Aug
26
2020
LEAP Eligible Practitioners Try Their Hand at Oral Advocacy in LEAP Mock Arguments before the PTAB Foley & Lardner LLP
Feb
20
2017
Federal Circuit Knocks Out Patents After CMB Challenge Foley & Lardner LLP
Mar
7
2017
Will Avastin Biosimilar Patent Dance Go On? Foley & Lardner LLP
Feb
25
2021
Arthrex’s Reply – Removing Tenure Doesn’t Solve the Problem and Defies Congressional Intent Foley & Lardner LLP
May
23
2017
CAFC Finds ANDA Infringement Despite Differences Between FDA Labeling And Claim Language Foley & Lardner LLP
May
3
2021
Sealing Judicial Records or How I Learned to Stop Consenting and Protect Trade Secrets Foley & Lardner LLP
Jun
22
2017
Is Congress Finally Getting Serious About Curtailing Design Patents in Auto Industry? Foley & Lardner LLP
Jul
11
2017
District Court Invalidates Dietary Supplement Patents On Motion To Dismiss Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins